Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G protein-coupled receptor activity	NPFFR2 GPRC5C TACR1 TACR3 HTR1F GRM3 LPAR1 ACKR3 OR4A47 HCRTR2	3.68e-07	884	30	10	GO:0004930
GeneOntologyMolecularFunction	neuropeptide receptor activity	NPFFR2 TACR1 TACR3 HCRTR2	1.15e-06	53	30	4	GO:0008188
GeneOntologyMolecularFunction	tachykinin receptor activity	TACR1 TACR3	6.54e-06	3	30	2	GO:0004995
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	NPFFR2 GPRC5C TACR1 TACR3 HTR1F GRM3 LPAR1 ACKR3 OR4A47 HCRTR2	1.69e-05	1353	30	10	GO:0004888
GeneOntologyMolecularFunction	G protein-coupled peptide receptor activity	NPFFR2 TACR1 TACR3 HCRTR2	4.51e-05	133	30	4	GO:0008528
GeneOntologyMolecularFunction	peptide receptor activity	NPFFR2 TACR1 TACR3 HCRTR2	5.51e-05	140	30	4	GO:0001653
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH2 DNAH10	3.29e-04	18	30	2	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH2 DNAH10	8.05e-04	28	30	2	GO:0051959
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH2 DNAH10	1.41e-03	37	30	2	GO:0045505
GeneOntologyMolecularFunction	metal cation:monoatomic cation antiporter activity	SLC24A5 SLC9B1	1.90e-03	43	30	2	GO:0140828
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC24A5 SLC9B1 SLC13A4	2.11e-03	171	30	3	GO:0015081
GeneOntologyMolecularFunction	protein phosphatase binding	AP3B1 AKAP1 PTK2	3.78e-03	210	30	3	GO:0019903
GeneOntologyMolecularFunction	microtubule motor activity	DNAH2 DNAH10	4.95e-03	70	30	2	GO:0003777
GeneOntologyMolecularFunction	phosphatase binding	AP3B1 AKAP1 PTK2	7.13e-03	264	30	3	GO:0019902
GeneOntologyBiologicalProcess	angiotensin-mediated drinking behavior	ACE2 TACR1	6.99e-06	3	32	2	GO:0003051
GeneOntologyBiologicalProcess	microtubule-based movement	DNAH2 SLC9B1 TACR1 TACR3 AP3B1 DNAH10 AP3B2	8.56e-06	493	32	7	GO:0007018
GeneOntologyBiologicalProcess	cilium movement involved in cell motility	DNAH2 SLC9B1 TACR1 TACR3 DNAH10	1.68e-05	210	32	5	GO:0060294
GeneOntologyBiologicalProcess	cilium or flagellum-dependent cell motility	DNAH2 SLC9B1 TACR1 TACR3 DNAH10	1.88e-05	215	32	5	GO:0001539
GeneOntologyBiologicalProcess	cilium-dependent cell motility	DNAH2 SLC9B1 TACR1 TACR3 DNAH10	1.88e-05	215	32	5	GO:0060285
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	NPFFR2 GPRC5C TACR1 TACR3 HTR1F GRM3 LPAR1 ACKR3 OR4A47 HCRTR2	3.16e-05	1395	32	10	GO:0007186
GeneOntologyBiologicalProcess	cilium movement	DNAH2 SLC9B1 TACR1 TACR3 DNAH10	4.75e-05	261	32	5	GO:0003341
GeneOntologyBiologicalProcess	antigen processing and presentation, exogenous lipid antigen via MHC class Ib	CD1C AP3B1	4.87e-05	7	32	2	GO:0048007
GeneOntologyBiologicalProcess	antigen processing and presentation of lipid antigen via MHC class Ib	CD1C AP3B1	4.87e-05	7	32	2	GO:0048003
GeneOntologyBiologicalProcess	clathrin-coated vesicle cargo loading	AP3B1 AP3B2	4.87e-05	7	32	2	GO:0035652
GeneOntologyBiologicalProcess	clathrin-coated vesicle cargo loading, AP-3-mediated	AP3B1 AP3B2	4.87e-05	7	32	2	GO:0035654
GeneOntologyBiologicalProcess	tachykinin receptor signaling pathway	TACR1 TACR3	6.49e-05	8	32	2	GO:0007217
GeneOntologyBiologicalProcess	brain renin-angiotensin system	ACE2 TACR1	8.34e-05	9	32	2	GO:0002035
GeneOntologyBiologicalProcess	positive regulation of uterine smooth muscle contraction	TACR1 TACR3	8.34e-05	9	32	2	GO:0070474
GeneOntologyBiologicalProcess	positive regulation of muscle contraction	ACE2 TACR1 TACR3	1.04e-04	59	32	3	GO:0045933
GeneOntologyBiologicalProcess	feeding behavior	ACE2 TACR1 TACR3 HCRTR2	1.11e-04	162	32	4	GO:0007631
GeneOntologyBiologicalProcess	regulation of muscle system process	ACE2 TACR1 TACR3 AKAP1 PTK2	1.19e-04	317	32	5	GO:0090257
GeneOntologyBiologicalProcess	regulation of uterine smooth muscle contraction	TACR1 TACR3	1.52e-04	12	32	2	GO:0070472
GeneOntologyBiologicalProcess	microtubule-based process	DNAH2 SLC9B1 TACR1 TACR3 AP3B1 DNAH10 PTK2 AP3B2	1.63e-04	1058	32	8	GO:0007017
GeneOntologyBiologicalProcess	uterine smooth muscle contraction	TACR1 TACR3	1.80e-04	13	32	2	GO:0070471
GeneOntologyBiologicalProcess	regulation of blood volume by renin-angiotensin	ACE2 TACR1	2.10e-04	14	32	2	GO:0002016
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	HTR1F GRM3 LPAR1	3.18e-04	86	32	3	GO:0007193
GeneOntologyBiologicalProcess	positive regulation of cilium-dependent cell motility	TACR1 TACR3	3.51e-04	18	32	2	GO:2000155
GeneOntologyBiologicalProcess	drinking behavior	ACE2 TACR1	3.51e-04	18	32	2	GO:0042756
GeneOntologyBiologicalProcess	positive regulation of flagellated sperm motility	TACR1 TACR3	3.51e-04	18	32	2	GO:1902093
GeneOntologyBiologicalProcess	positive regulation of cilium movement	TACR1 TACR3	3.92e-04	19	32	2	GO:0003353
GeneOntologyBiologicalProcess	anterograde synaptic vesicle transport	AP3B1 AP3B2	5.28e-04	22	32	2	GO:0048490
GeneOntologyBiologicalProcess	synaptic vesicle cytoskeletal transport	AP3B1 AP3B2	5.28e-04	22	32	2	GO:0099514
GeneOntologyBiologicalProcess	synaptic vesicle transport along microtubule	AP3B1 AP3B2	5.28e-04	22	32	2	GO:0099517
GeneOntologyBiologicalProcess	nervous system process involved in regulation of systemic arterial blood pressure	ACE2 TACR1	6.30e-04	24	32	2	GO:0001976
GeneOntologyBiologicalProcess	antigen processing and presentation via MHC class Ib	CD1C AP3B1	6.84e-04	25	32	2	GO:0002475
GeneOntologyBiologicalProcess	positive regulation of cell motility	CLEC7A TACR1 TACR3 LPAR1 ACKR3 PTK2	7.66e-04	725	32	6	GO:2000147
GeneOntologyBiologicalProcess	regulation of system process	ACE2 TACR1 TACR3 GRM3 AKAP1 PTK2	8.17e-04	734	32	6	GO:0044057
GeneOntologyBiologicalProcess	regulation of flagellated sperm motility	TACR1 TACR3	8.60e-04	28	32	2	GO:1901317
GeneOntologyBiologicalProcess	positive regulation of locomotion	CLEC7A TACR1 TACR3 LPAR1 ACKR3 PTK2	8.64e-04	742	32	6	GO:0040017
GeneOntologyBiologicalProcess	regulation of smooth muscle cell migration	TACR1 LPAR1 PTK2	1.16e-03	134	32	3	GO:0014910
GeneOntologyBiologicalProcess	positive regulation of smooth muscle contraction	TACR1 TACR3	1.42e-03	36	32	2	GO:0045987
GeneOntologyBiologicalProcess	vesicle cargo loading	AP3B1 AP3B2	1.42e-03	36	32	2	GO:0035459
GeneOntologyBiologicalProcess	muscle system process	ACE2 TACR1 TACR3 AKAP1 PTK2	1.43e-03	547	32	5	GO:0003012
GeneOntologyBiologicalProcess	smooth muscle cell migration	TACR1 LPAR1 PTK2	1.45e-03	145	32	3	GO:0014909
GeneOntologyBiologicalProcess	regulation of systemic arterial blood pressure by renin-angiotensin	ACE2 TACR1	1.50e-03	37	32	2	GO:0003081
GeneOntologyBiologicalProcess	regulation of cilium movement involved in cell motility	TACR1 TACR3	1.50e-03	37	32	2	GO:0060295
GeneOntologyBiologicalProcess	regulation of cilium-dependent cell motility	TACR1 TACR3	1.50e-03	37	32	2	GO:1902019
GeneOntologyBiologicalProcess	endocytosis	CLEC7A ACE2 LPAR1 ACKR3 PTK2 AP3B2	1.51e-03	827	32	6	GO:0006897
GeneOntologyCellularComponent	9+2 motile cilium	DNAH2 EFCAB2 SLC9B1 TACR1 TACR3 DNAH10	1.45e-06	238	32	6	GO:0097729
GeneOntologyCellularComponent	motile cilium	DNAH2 EFCAB2 SLC9B1 TACR1 TACR3 DNAH10	1.43e-05	355	32	6	GO:0031514
GeneOntologyCellularComponent	sperm flagellum	DNAH2 EFCAB2 SLC9B1 TACR1 TACR3	1.73e-05	214	32	5	GO:0036126
GeneOntologyCellularComponent	cilium	DNAH2 EFCAB2 ACE2 SLC9B1 TACR1 TACR3 DNAH10 PTK2	4.71e-05	898	32	8	GO:0005929
GeneOntologyCellularComponent	inner dynein arm	DNAH2 DNAH10	1.01e-04	10	32	2	GO:0036156
GeneOntologyCellularComponent	AP-3 adaptor complex	AP3B1 AP3B2	1.75e-04	13	32	2	GO:0030123
GeneOntologyCellularComponent	axonemal dynein complex	DNAH2 DNAH10	6.66e-04	25	32	2	GO:0005858
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	DNAH2 AP3B1 DNAH10 AP3B2	1.33e-03	317	32	4	GO:0032838
GeneOntologyCellularComponent	endosome	CD1C AP3B1 SPAAR LPAR1 ACKR3 LDLRAD4 AP3B2	1.63e-03	1167	32	7	GO:0005768
GeneOntologyCellularComponent	dendrite	TACR1 TACR3 HTR1F GRM3 LPAR1 PTK2	1.70e-03	858	32	6	GO:0030425
GeneOntologyCellularComponent	dendritic tree	TACR1 TACR3 HTR1F GRM3 LPAR1 PTK2	1.73e-03	860	32	6	GO:0097447
GeneOntologyCellularComponent	sperm principal piece	EFCAB2 SLC9B1	2.06e-03	44	32	2	GO:0097228
GeneOntologyCellularComponent	cytoplasmic region	DNAH2 AP3B1 DNAH10 AP3B2	2.13e-03	360	32	4	GO:0099568
GeneOntologyCellularComponent	AP-type membrane coat adaptor complex	AP3B1 AP3B2	2.45e-03	48	32	2	GO:0030119
GeneOntologyCellularComponent	dynein complex	DNAH2 DNAH10	3.09e-03	54	32	2	GO:0030286
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	ACE2 CD1C GPRC5C AP3B1 SPAAR LDLRAD4 AP3B2	3.11e-03	1307	32	7	GO:0030659
GeneOntologyCellularComponent	vesicle membrane	ACE2 CD1C GPRC5C AP3B1 SPAAR LDLRAD4 AP3B2	3.35e-03	1325	32	7	GO:0012506
GeneOntologyCellularComponent	sperm midpiece	TACR1 TACR3	4.31e-03	64	32	2	GO:0097225
GeneOntologyCellularComponent	axon cytoplasm	AP3B1 AP3B2	4.86e-03	68	32	2	GO:1904115
GeneOntologyCellularComponent	dendritic spine	GRM3 LPAR1 PTK2	5.93e-03	242	32	3	GO:0043197
GeneOntologyCellularComponent	early endosome	AP3B1 ACKR3 LDLRAD4 AP3B2	5.98e-03	481	32	4	GO:0005769
GeneOntologyCellularComponent	cell surface	CLEC7A ACE2 CD1C TACR1 LPAR1 ACKR3	6.13e-03	1111	32	6	GO:0009986
GeneOntologyCellularComponent	neuron spine	GRM3 LPAR1 PTK2	6.28e-03	247	32	3	GO:0044309
Domain	AP3_beta	AP3B1 AP3B2	2.67e-06	2	31	2	IPR026740
Domain	AP3B1_C	AP3B1 AP3B2	2.67e-06	2	31	2	PF14796
Domain	AP3B1_C	AP3B1 AP3B2	2.67e-06	2	31	2	SM01355
Domain	AP3B_C	AP3B1 AP3B2	2.67e-06	2	31	2	IPR029390
Domain	Neurokn_rcpt	TACR1 TACR3	7.99e-06	3	31	2	IPR001681
Domain	GPCR_Rhodpsn_7TM	NPFFR2 TACR1 TACR3 HTR1F LPAR1 ACKR3 OR4A47 HCRTR2	9.98e-06	670	31	8	IPR017452
Domain	7tm_1	NPFFR2 TACR1 TACR3 HTR1F LPAR1 ACKR3 OR4A47 HCRTR2	1.08e-05	677	31	8	PF00001
Domain	G_PROTEIN_RECEP_F1_1	NPFFR2 TACR1 TACR3 HTR1F LPAR1 ACKR3 OR4A47 HCRTR2	1.17e-05	685	31	8	PS00237
Domain	G_PROTEIN_RECEP_F1_2	NPFFR2 TACR1 TACR3 HTR1F LPAR1 ACKR3 OR4A47 HCRTR2	1.25e-05	691	31	8	PS50262
Domain	GPCR_Rhodpsn	NPFFR2 TACR1 TACR3 HTR1F LPAR1 ACKR3 OR4A47 HCRTR2	1.26e-05	692	31	8	IPR000276
Domain	AP_beta	AP3B1 AP3B2	2.66e-05	5	31	2	IPR026739
Domain	7TM_GPCR_Srsx	NPFFR2 HTR1F LPAR1 HCRTR2	3.40e-05	112	31	4	SM01381
Domain	Dynein_heavy_dom-1	DNAH2 DNAH10	7.42e-05	8	31	2	IPR013594
Domain	DHC_N1	DNAH2 DNAH10	7.42e-05	8	31	2	PF08385
Domain	ATPase_dyneun-rel_AAA	DNAH2 DNAH10	2.40e-04	14	31	2	IPR011704
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DNAH10	2.40e-04	14	31	2	IPR024317
Domain	Dynein_HC_stalk	DNAH2 DNAH10	2.40e-04	14	31	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH2 DNAH10	2.40e-04	14	31	2	IPR013602
Domain	DHC_N2	DNAH2 DNAH10	2.40e-04	14	31	2	PF08393
Domain	MT	DNAH2 DNAH10	2.40e-04	14	31	2	PF12777
Domain	AAA_8	DNAH2 DNAH10	2.40e-04	14	31	2	PF12780
Domain	AAA_5	DNAH2 DNAH10	2.40e-04	14	31	2	PF07728
Domain	DHC_fam	DNAH2 DNAH10	2.76e-04	15	31	2	IPR026983
Domain	Clathrin/coatomer_adapt-like_N	AP3B1 AP3B2	2.76e-04	15	31	2	IPR002553
Domain	Adaptin_N	AP3B1 AP3B2	2.76e-04	15	31	2	PF01602
Domain	Dynein_heavy_dom	DNAH2 DNAH10	2.76e-04	15	31	2	IPR004273
Domain	Dynein_heavy	DNAH2 DNAH10	2.76e-04	15	31	2	PF03028
Domain	GPCR_3	GPRC5C GRM3	5.49e-04	21	31	2	IPR000337
Domain	G_PROTEIN_RECEP_F3_4	GPRC5C GRM3	6.03e-04	22	31	2	PS50259
Domain	7tm_3	GPRC5C GRM3	6.03e-04	22	31	2	PF00003
Domain	GPCR_3_C	GPRC5C GRM3	6.03e-04	22	31	2	IPR017978
Domain	G_PROTEIN_RECEP_F3_2	GPRC5C GRM3	6.03e-04	22	31	2	PS00980
Domain	G_PROTEIN_RECEP_F3_3	GPRC5C GRM3	6.03e-04	22	31	2	PS00981
Domain	G_PROTEIN_RECEP_F3_1	GPRC5C GRM3	6.03e-04	22	31	2	PS00979
Domain	LDLR_class-A_CS	MFRP LDLRAD4	2.00e-03	40	31	2	IPR023415
Domain	Ldl_recept_a	MFRP LDLRAD4	2.52e-03	45	31	2	PF00057
Domain	-	MFRP LDLRAD4	2.64e-03	46	31	2	4.10.400.10
Domain	LDLRA_1	MFRP LDLRAD4	2.87e-03	48	31	2	PS01209
Domain	LDrepeatLR_classA_rpt	MFRP LDLRAD4	2.99e-03	49	31	2	IPR002172
Domain	LDLa	MFRP LDLRAD4	2.99e-03	49	31	2	SM00192
Domain	LDLRA_2	MFRP LDLRAD4	2.99e-03	49	31	2	PS50068
Domain	ZINC_PROTEASE	ACE2 ADAM12	1.15e-02	98	31	2	PS00142
Pathway	WP_GPCRS_NONODORANT	NPFFR2 TACR1 TACR3 HTR1F GRM3 LPAR1 ACKR3 HCRTR2	2.35e-08	266	27	8	MM15843
Pathway	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	NPFFR2 TACR1 TACR3 HTR1F GRM3 LPAR1 HCRTR2	5.88e-07	272	27	7	M13380
Pathway	REACTOME_GPCR_LIGAND_BINDING	NPFFR2 TACR1 TACR3 HTR1F GRM3 LPAR1 ACKR3 HCRTR2	9.36e-07	430	27	8	MM15160
Pathway	REACTOME_GPCR_LIGAND_BINDING	NPFFR2 TACR1 TACR3 HTR1F GRM3 LPAR1 ACKR3 HCRTR2	1.63e-06	463	27	8	M507
Pathway	REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS	NPFFR2 TACR1 TACR3 HTR1F LPAR1 ACKR3 HCRTR2	2.14e-06	330	27	7	M18334
Pathway	REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS	NPFFR2 TACR1 TACR3 HTR1F LPAR1 ACKR3 HCRTR2	2.28e-06	333	27	7	MM14963
Pathway	REACTOME_SIGNALING_BY_GPCR	NPFFR2 TACR1 TACR3 HTR1F GRM3 LPAR1 ACKR3 HCRTR2	1.90e-05	646	27	8	MM14962
Pathway	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	NPFFR2 TACR1 TACR3 ACKR3 HCRTR2	3.18e-05	197	27	5	M12289
Pathway	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	NPFFR2 TACR1 TACR3 ACKR3 HCRTR2	3.18e-05	197	27	5	MM14970
Pathway	REACTOME_SIGNALING_BY_GPCR	NPFFR2 TACR1 TACR3 HTR1F GRM3 LPAR1 ACKR3 HCRTR2	3.47e-05	702	27	8	M746
Pathway	REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS	TACR1 TACR3	3.52e-05	5	27	2	M27277
Pathway	REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS	TACR1 TACR3	3.52e-05	5	27	2	MM14977
Pathway	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	NPFFR2 TACR1 TACR3 LPAR1 HCRTR2	4.32e-05	210	27	5	MM15043
Pathway	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	NPFFR2 TACR1 TACR3 LPAR1 HCRTR2	5.05e-05	217	27	5	M18437
Pathway	REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS	NPFFR2 HCRTR2	9.82e-05	8	27	2	M27291
Pathway	REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS	NPFFR2 HCRTR2	9.82e-05	8	27	2	MM14995
Pathway	WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE	GPRC5C GRM3	3.65e-04	15	27	2	M39442
Pathway	WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE	GPRC5C GRM3	3.65e-04	15	27	2	MM15845
Pathway	WP_PEPTIDE_GPCRS	TACR1 TACR3 HCRTR2	3.86e-04	75	27	3	M39696
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH2 DNAH10	1.20e-03	27	27	2	M47755
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	NPFFR2 HTR1F ACKR3 HCRTR2	1.42e-03	260	27	4	M39397
Pathway	PID_SYNDECAN_4_PATHWAY	ADAM12 PTK2	1.69e-03	32	27	2	M165
Pathway	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	HTR1F GRM3 LPAR1 ACKR3	2.09e-03	289	27	4	MM15057
Pathway	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	HTR1F GRM3 LPAR1 ACKR3	2.83e-03	314	27	4	M600
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	DNAH2 DNAH10	3.04e-03	43	27	2	M47669
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH2 DNAH10	3.32e-03	45	27	2	M47670
Pubmed	Stable association between G alpha(q) and phospholipase C beta 1 in living cells.	NPFFR2 TACR1 TACR3 LPAR1 HCRTR2	2.60e-08	95	32	5	16754659
Pubmed	FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes.	FNDC5 FNDC4	8.20e-07	2	32	2	34465884
Pubmed	The primary structure and gene organization of human substance P and neuromedin K receptors.	TACR1 TACR3	8.20e-07	2	32	2	1312928
Pubmed	Neurokinin receptors in drug and alcohol addiction.	TACR1 TACR3	8.20e-07	2	32	2	32067964
Pubmed	Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor.	TACR1 TACR3	8.20e-07	2	32	2	8120392
Pubmed	An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.	ADAM12 PTK2	8.20e-07	2	32	2	29476791
Pubmed	Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes.	FNDC5 FNDC4	8.20e-07	2	32	2	12384288
Pubmed	Irisin and the fibronectin type III domain-containing family: structure, signaling and role in female reproduction.	FNDC5 FNDC4	8.20e-07	2	32	2	35521900
Pubmed	ACE2 improves endothelial cell function and reduces acute lung injury by downregulating FAK expression.	ACE2 PTK2	8.20e-07	2	32	2	38246001
Pubmed	The AP-3 complex required for endosomal synaptic vesicle biogenesis is associated with a casein kinase Ialpha-like isoform.	AP3B1 AP3B2	2.46e-06	3	32	2	10930456
Pubmed	Expression and coupling of neurokinin receptor subtypes to inositol phosphate and calcium signaling pathways in human airway smooth muscle cells.	TACR1 TACR3	2.46e-06	3	32	2	18203813
Pubmed	Tachykinins regulate the function of platelets.	TACR1 TACR3	2.46e-06	3	32	2	15130944
Pubmed	Molecular cloning of the murine substance K and substance P receptor genes.	TACR1 TACR3	2.46e-06	3	32	2	1370937
Pubmed	Expression of the tachykinin receptor mRNAs in healthy human colon.	TACR1 TACR3	2.46e-06	3	32	2	18835556
Pubmed	The unpredicted high affinities of a large number of naturally occurring tachykinins for chimeric NK1/NK3 receptors suggest a role for an inhibitory domain in determining receptor specificity.	TACR1 TACR3	4.92e-06	4	32	2	8702757
Pubmed	Regulation of large dense-core vesicle volume and neurotransmitter content mediated by adaptor protein 3.	AP3B1 AP3B2	4.92e-06	4	32	2	16788073
Pubmed	Expression of substance P, neurokinin 1 receptors (NK1) and neurokinin 3 receptors in the developing mouse retina and in the retina of NK1 knockout mice.	TACR1 TACR3	4.92e-06	4	32	2	16388914
Pubmed	Adaptor protein-3 produces synaptic vesicles that release phasic dopamine.	AP3B1 AP3B2	8.19e-06	5	32	2	37812725
Pubmed	Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism.	SLC24A5 AP3B1	8.19e-06	5	32	2	23364476
Pubmed	Association analysis between schizophrenia and the AP-3 complex genes.	AP3B1 AP3B2	8.19e-06	5	32	2	19481122
Pubmed	Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.	TACR1 TACR3	8.19e-06	5	32	2	11786503
Pubmed	A role for tachykinins in female mouse and rat reproductive function.	TACR1 TACR3	1.23e-05	6	32	2	12773411
Pubmed	Characterization of the endokinins: human tachykinins with cardiovascular activity.	TACR1 TACR3	1.23e-05	6	32	2	12716968
Pubmed	A role for tachykinins in the regulation of human sperm motility.	TACR1 TACR3	1.23e-05	6	32	2	17437961
Pubmed	Genetic analysis of the neuronal and ubiquitous AP-3 adaptor complexes reveals divergent functions in brain.	AP3B1 AP3B2	1.23e-05	6	32	2	15537701
Pubmed	Characterization of the adaptor-related protein complex, AP-3.	AP3B1 AP3B2	1.72e-05	7	32	2	9151686
Pubmed	Dissociation of heterotrimeric g proteins in cells.	TACR3 HTR1F LPAR1 ACKR3	2.18e-05	179	32	4	18577758
Pubmed	TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.	LPAR1 PTK2	2.29e-05	8	32	2	14688263
Pubmed	Application of HapMap data to the evaluation of 8 candidate genes for pediatric slow transit constipation.	TACR1 TACR3	2.29e-05	8	32	2	17448763
Pubmed	Association of the AP-3 adaptor complex with clathrin.	AP3B1 AP3B2	2.29e-05	8	32	2	9545220
Pubmed	AP-3 and Rabip4' coordinately regulate spatial distribution of lysosomes.	AP3B1 AP3B2	2.94e-05	9	32	2	23144738
Pubmed	Regulation of arrestin-3 phosphorylation by casein kinase II.	AP3B1 AP3B2	3.67e-05	10	32	2	11877451
Pubmed	HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.	AP3B1 AP3B2	3.67e-05	10	32	2	18076669
Pubmed	Neural basis of opioid-induced respiratory depression and its rescue.	TACR1 TACR3	3.67e-05	10	32	2	34074761
Pubmed	Roles of BLOC-1 and adaptor protein-3 complexes in cargo sorting to synaptic vesicles.	AP3B1 AP3B2	5.38e-05	12	32	2	19144828
Pubmed	Tlx1/3 and Ptf1a control the expression of distinct sets of transmitter and peptide receptor genes in the developing dorsal spinal cord.	TACR1 TACR3 GRM3	5.75e-05	81	32	3	22723691
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH2 DNAH10	7.41e-05	14	32	2	9373155
Pubmed	Cell type-specific Rab32 and Rab38 cooperate with the ubiquitous lysosome biogenesis machinery to synthesize specialized lysosome-related organelles.	AP3B1 AP3B2	9.76e-05	16	32	2	23247405
Pubmed	WNT/β-catenin signaling plays a crucial role in myoblast fusion through regulation of nephrin expression during development.	ADAM12 PTK2	1.24e-04	18	32	2	30389854
Pubmed	The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapse.	AP3B1 AP3B2	1.24e-04	18	32	2	21998198
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	TACR1 HTR1F GRM3 HCRTR2	1.61e-04	300	32	4	19086053
Pubmed	A library of 7TM receptor C-terminal tails. Interactions with the proposed post-endocytic sorting proteins ERM-binding phosphoprotein 50 (EBP50), N-ethylmaleimide-sensitive factor (NSF), sorting nexin 1 (SNX1), and G protein-coupled receptor-associated sorting protein (GASP).	TACR1 TACR3	1.70e-04	21	32	2	15452121
Pubmed	Growth suppression of Escherichia coli by induction of expression of mammalian genes with transmembrane or ATPase domains.	FNDC4 AP3B2	2.24e-04	24	32	2	10679242
Pubmed	Endocardial Brg1 disruption illustrates the developmental origins of semilunar valve disease.	CLEC7A ACKR3	2.43e-04	25	32	2	26100917
Pubmed	The AP-3 complex: a coat of many colours.	AP3B1 AP3B2	3.05e-04	28	32	2	9714600
Pubmed	Dlx1&2-dependent expression of Zfhx1b (Sip1, Zeb2) regulates the fate switch between cortical and striatal interneurons.	TACR1 ACKR3	3.75e-04	31	32	2	23312518
Pubmed	Expression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and development.	LPAR1 SGPP2	6.26e-04	40	32	2	21319224
Pubmed	Phox2a Defines a Developmental Origin of the Anterolateral System in Mice and Humans.	TACR1 TACR3	6.26e-04	40	32	2	33238113
Pubmed	Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.	TACR1 TACR3	7.23e-04	43	32	2	23597562
Interaction	TM9SF3 interactions	FNDC5 ACE2 TACR1 AKAP1 LPAR1	1.74e-06	143	29	5	int:TM9SF3
Interaction	KTN1 interactions	CLEC7A ACE2 TACR3 AKAP1 LPAR1 PTK2	6.48e-06	331	29	6	int:KTN1
Interaction	TAC4 interactions	TACR1 TACR3	1.20e-05	4	29	2	int:TAC4
Interaction	NDUFB3 interactions	FNDC5 FNDC4 TACR1 LPAR1	1.73e-05	109	29	4	int:NDUFB3
Interaction	CERS5 interactions	FNDC5 TACR3 LPAR1	1.85e-05	36	29	3	int:CERS5
Interaction	TMPRSS11D interactions	FNDC5 ACE2	1.99e-05	5	29	2	int:TMPRSS11D
Interaction	TSPAN15 interactions	GPRC5C TACR1 TACR3 LPAR1 HCRTR2	4.21e-05	276	29	5	int:TSPAN15
Interaction	SLC39A1 interactions	FNDC5 ACE2 LPAR1	4.44e-05	48	29	3	int:SLC39A1
Interaction	SELENOT interactions	FNDC5 LPAR1 HCRTR2	4.72e-05	49	29	3	int:SELENOT
Interaction	HCRT interactions	NPFFR2 HCRTR2	5.57e-05	8	29	2	int:HCRT
Interaction	CD320 interactions	FNDC5 ACE2 ALG6	9.12e-05	61	29	3	int:CD320
Interaction	LMBRD2 interactions	TACR1 TACR3 HCRTR2	1.10e-04	65	29	3	int:LMBRD2
Interaction	AP3D1 interactions	FNDC5 ACE2 AP3B1 AP3B2	1.13e-04	176	29	4	int:AP3D1
Interaction	STT3A interactions	DNAH2 FNDC5 ACE2 AKAP1	1.20e-04	179	29	4	int:STT3A
Interaction	TAC1 interactions	TACR1 TACR3	1.31e-04	12	29	2	int:TAC1
Interaction	ARL10 interactions	TACR3 AKAP1 LPAR1 HCRTR2	1.48e-04	189	29	4	int:ARL10
Interaction	LPCAT3 interactions	FNDC5 TACR1 LPAR1	2.04e-04	80	29	3	int:LPCAT3
Interaction	HACD2 interactions	FNDC5 TACR1 LPAR1	2.20e-04	82	29	3	int:HACD2
Interaction	FADS1 interactions	FNDC5 TACR1 HCRTR2	2.62e-04	87	29	3	int:FADS1
Interaction	AGPAT3 interactions	FNDC5 FNDC4 PTK2	2.71e-04	88	29	3	int:AGPAT3
Interaction	TMEM147 interactions	FNDC5 TACR1 SLC13A4	2.71e-04	88	29	3	int:TMEM147
Interaction	RNF121 interactions	FNDC5 LPAR1	3.02e-04	18	29	2	int:RNF121
Interaction	TAC3 interactions	TACR1 TACR3	3.02e-04	18	29	2	int:TAC3
Interaction	TAMALIN interactions	ACE2 GRM3	3.37e-04	19	29	2	int:TAMALIN
Interaction	TMEM126A interactions	FNDC5 TACR1 LPAR1	3.72e-04	98	29	3	int:TMEM126A
Interaction	AKR1C1 interactions	FNDC5 ACE2	3.74e-04	20	29	2	int:AKR1C1
Interaction	MYADM interactions	FNDC5 TACR3 HCRTR2	4.06e-04	101	29	3	int:MYADM
Interaction	F13A1 interactions	FNDC5 PTK2	4.13e-04	21	29	2	int:F13A1
Interaction	MAOA interactions	FNDC5 AKAP1	4.13e-04	21	29	2	int:MAOA
Interaction	GPRC5C interactions	GPRC5C TACR1 LPAR1	4.30e-04	103	29	3	int:GPRC5C
Interaction	TMEM11 interactions	FNDC5 TACR3 LPAR1	4.55e-04	105	29	3	int:TMEM11
Cytoband	Ensembl 112 genes in cytogenetic band chr4q24	SLC9B1 TACR3	7.86e-04	59	32	2	chr4q24
GeneFamily	Tachykinin receptors	TACR1 TACR3	5.96e-06	3	26	2	258
GeneFamily	Dyneins, axonemal	DNAH2 DNAH10	2.67e-04	17	26	2	536
GeneFamily	Solute carriers	SLC24A5 SLC9B1 SLC13A4	1.85e-02	395	26	3	752
GeneFamily	Fibronectin type III domain containing	FNDC5 FNDC4	2.20e-02	160	26	2	555
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	AKAP1 PTK2	2.77e-02	181	26	2	694
Coexpression	ROSS_AML_WITH_CBFB_MYH11_FUSION	CLEC7A CD1C LPAR1	3.18e-05	52	31	3	M5236
Coexpression	GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	SLC24A5 HTR1F DNAH10 AP3B2	7.08e-05	189	31	4	M6494
Coexpression	HALLMARK_INFLAMMATORY_RESPONSE	NPFFR2 TACR1 TACR3 LPAR1	8.81e-05	200	31	4	M5932
Coexpression	YOSHIMURA_MAPK8_TARGETS_UP	DNAH2 ACE2 GPRC5C TACR1 HTR1F GRM3 AKAP1 PTK2	9.17e-05	1281	31	8	M1884
ToppCell	Severe-Myeloid-Mast-\|Severe / Condition, Lineage, Cell class and cell subclass	SLC24A5 TACR1 HTR1F ADAM12	3.47e-06	145	32	4	ce307d45425a5191882078f049f85477eec40b69
ToppCell	Severe-Myeloid-Mast\|Severe / Condition, Lineage, Cell class and cell subclass	SLC24A5 TACR1 HTR1F ADAM12	3.47e-06	145	32	4	e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell-Peri\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ACE2 GPRC5C SPAAR ACKR3	4.52e-06	155	32	4	d8b5145258f075b15080f8739f537f48dd22225e
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ACE2 GPRC5C SPAAR ACKR3	4.52e-06	155	32	4	ced64e26962c5c6e6d539f361fe57ab0b399e999
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ACE2 GPRC5C SPAAR ACKR3	4.52e-06	155	32	4	0f24ef6486aef354f0911c06932cb01d1a0525ac
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRC5C DNAH10 ADAM12 SPAAR	7.30e-06	175	32	4	0801cccec6915aefc135262fc74580280fd51aa5
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRC5C DNAH10 ADAM12 SPAAR	7.30e-06	175	32	4	09163e7030f76d706eccabdb1d5ec45f8412aa75
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ACE2 GPRC5C SPAAR	7.26e-05	113	32	3	0651fb7a7e1ea84b8365059e5ed85bf6c082da1a
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ACE2 GPRC5C SPAAR	7.26e-05	113	32	3	0e153efddd061d7510dfc3859cc8b1a7984fa70e
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TACR1 ACKR3 HCRTR2	8.05e-05	117	32	3	0602bbad908cb28c5093b74d717da5f2af577943
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ACE2 GPRC5C SPAAR	8.67e-05	120	32	3	3e1ae5a5422729d484a90d72f779833fe3473fa8
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ACE2 GPRC5C SPAAR	8.67e-05	120	32	3	24d5e86931a857bb87684392172bf04294a1a46a
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ACE2 GPRC5C SPAAR	8.67e-05	120	32	3	e60b74758c8290919b326904ad841962256b72ec
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TACR1 ACKR3 HCRTR2	8.67e-05	120	32	3	a4e3f9a83bc52ccc75bcd64b1be4e2c5441f6d1a
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH2 TACR1 SGPP2	1.12e-04	131	32	3	419a0a83b38eaea890d065c3f252ef83c2d37b5b
ToppCell	Mild/Remission-B_intermediate-14\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CD1C DNAH10 ACKR3	1.20e-04	134	32	3	5bd1e3fa6278facd9e949e9e5e244e700190126b
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ACE2 GPRC5C SPAAR	1.23e-04	135	32	3	e908aacb72a8c340f06cf5b4a6b70c2faac4d027
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	FNDC4 MFRP LPAR1	1.28e-04	137	32	3	25b5370b63644351efddb8749ef174beca0581cd
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DNAH10 ADAM12 LPAR1	1.28e-04	137	32	3	dd5364a1002650d21e0c83d8c701b5f7b09d1c19
ToppCell	Mild/Remission-B_intermediate-14\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CD1C DNAH10 ACKR3	1.40e-04	141	32	3	69e32125a0e8f0c8561e5e7a93607f368f09546f
ToppCell	facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLEC7A HTR1F ADAM12	1.49e-04	144	32	3	8bd042f12186f36bc5aabf6a0232270a448f4b58
ToppCell	mild_COVID-19_(asymptomatic)-Treg\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	SLC9B1 ADAM12 SGPP2	1.52e-04	145	32	3	2d0903009e918500facfd017ff31f2cec1e76131
ToppCell	mild_COVID-19_(asymptomatic)-Treg\|World / disease group, cell group and cell class (v2)	SLC9B1 ADAM12 SGPP2	1.52e-04	145	32	3	a3b0e1d0ce0caa8b281a146439d6455db64cc3e5
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TACR1 ADAM12 LPAR1	1.55e-04	146	32	3	86cddd0e7f954547b7ffdccb0329cd5c4b725ac1
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD1C DNAH10 ACKR3	1.61e-04	148	32	3	6ffa212f0cc44c40d2143816dc6cfd82fbf09a33
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FNDC5 CD1C DNAH10	1.78e-04	153	32	3	91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FNDC5 CD1C DNAH10	1.78e-04	153	32	3	f17f62646633cf95c810dcd5328978058741b276
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TACR1 ADAM12 LPAR1	1.96e-04	158	32	3	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GPRC5C ADAM12 SPAAR	1.96e-04	158	32	3	32c95c1bc9e50fccd6d06e828f29258fc5e568cb
ToppCell	367C-Fibroblasts-Fibroblast-F\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FNDC5 DNAH10 ACKR3	2.07e-04	161	32	3	c61283c301a87bb802f6f8ce79c26067032dd7d9
ToppCell	367C-Fibroblasts-Fibroblast-F-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FNDC5 DNAH10 ACKR3	2.07e-04	161	32	3	9864d8b0929dacf4be7a4e97d2527ac3120ea264
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NPFFR2 CD1C ADAM12	2.14e-04	163	32	3	e4077e587895c85bc806be05ff5d451088e39468
ToppCell	facs-Heart-LA-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNDC5 EFCAB2 TACR1	2.22e-04	165	32	3	95866f7cc6eb1bb51a034a104a0eb2a53b0256f2
ToppCell	368C-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	DNAH2 LPAR1 ACKR3	2.22e-04	165	32	3	9d2bdc42c13c8c2a68889bec8612a1ce56f659fa
ToppCell	facs-Heart-LA-18m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNDC5 EFCAB2 TACR1	2.22e-04	165	32	3	f8bfe336b9a4460b9349c01acd0bd3167812662f
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TACR1 DNAH10 SGPP2	2.30e-04	167	32	3	cf6206c506715cd846799c62cf7c06e3fa99f7af
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like\|GI_small-bowel / Manually curated celltypes from each tissue	GPRC5C ADAM12 LPAR1	2.34e-04	168	32	3	d02eba7ece17edcdd47fd6b784c93910ce61090f
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TACR1 DNAH10 SGPP2	2.38e-04	169	32	3	30141f76e9bfc2b4586429857c72dbc85ba65cc9
ToppCell	COVID-19_Convalescent-cDC-\|COVID-19_Convalescent / Disease condition and Cell class	CD1C DNAH10 PTK2	2.47e-04	171	32	3	fb5fae8b3adafcbb7c5618d887966b418355ed4d
ToppCell	COVID-19_Convalescent-cDC\|COVID-19_Convalescent / Disease condition and Cell class	CD1C DNAH10 PTK2	2.47e-04	171	32	3	9ccaa9f1629818b0f63a5d930ee78c01e04cd98d
ToppCell	facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRC5C GRM3 ADAM12	2.51e-04	172	32	3	b3c4adccc34bb9e4e78e40f4e2e23736c347cc75
ToppCell	facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRC5C GRM3 ADAM12	2.51e-04	172	32	3	2f1673fcb2356684d60871debb0f159aec553a1c
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	FNDC5 TACR1 TACR3	2.55e-04	173	32	3	7e3897868dd3f6e4974f593c60649a543ffc8693
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 GPRC5C ACKR3	2.55e-04	173	32	3	2acd0693a2dfe04e3c1b2125ea63efe92d13150b
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 GPRC5C ACKR3	2.55e-04	173	32	3	2415b6ff49f334da570577d4e93484d024a3dbd5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC4 TACR1 SPAAR	2.60e-04	174	32	3	3d4c05ea5719ca65e85d1f15198453034791087c
ToppCell	droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPRC5C SPAAR PTK2	2.69e-04	176	32	3	e2b59a904c5c8f9c88e1e63788e9b6485f22edd0
ToppCell	droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPRC5C SPAAR PTK2	2.69e-04	176	32	3	f931192e3cc65414e2245354f443473696cc7ce8
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FNDC4 NPFFR2 HTR1F	2.73e-04	177	32	3	8c6d8a1c469346e66f9095d86b4615f8fc611362
ToppCell	normal_Lymph_Node-Myeloid_cells-Pleural_Mac\|normal_Lymph_Node / Location, Cell class and cell subclass	CLEC7A CD1C LPAR1	2.91e-04	181	32	3	921e917f83105896ad8918dc134b871708024021
ToppCell	390C-Myeloid-Dendritic-cDC1\|390C / Donor, Lineage, Cell class and subclass (all cells)	CLEC7A SLC13A4 LDLRAD4	2.91e-04	181	32	3	d1c69171600b2d2aec96fa86fa757b588c265f7c
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ACE2 GPRC5C ADAM12	2.96e-04	182	32	3	ba066ff9029cc052b76e2330ec168cb2e9b7e498
ToppCell	tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs\|tumor_Lung / Location, Cell class and cell subclass	CLEC7A FNDC4 CD1C	2.96e-04	182	32	3	243779ba1009097f8fafa1a691e296ec3aeefc04
ToppCell	Globus_pallidus-Neuronal-Inhibitory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	FNDC5 TACR1 TACR3	2.96e-04	182	32	3	04ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HTR1F GRM3 ADAM12	2.96e-04	182	32	3	fc4a5bf784705efe7965ce43ac23c2a8e602e90a
ToppCell	3'_v3-GI_small-bowel-Myeloid_Dendritic\|GI_small-bowel / Manually curated celltypes from each tissue	CLEC7A CD1C PTK2	3.01e-04	183	32	3	6109199cf25b28831193a5ed7925b5bf38c6eb43
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 GPRC5C ACKR3	3.06e-04	184	32	3	89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 GPRC5C ACKR3	3.06e-04	184	32	3	34c84ac9a32eaf96f45b79485119cad65905817d
ToppCell	(1)_T_cells-(1)_T_regulatory\|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	CLEC7A ADAM12 SGPP2	3.06e-04	184	32	3	3cbf81757653652441843d85cb7ec1dcf25ca1b0
ToppCell	Control-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	ADAM12 LDLRAD4 SGPP2	3.11e-04	185	32	3	e481cacda0b6b25f5f0062b962df9a442053ac30
ToppCell	droplet-Heart-4Chambers-21m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRC5C DNAH10 ADAM12	3.11e-04	185	32	3	bb5a4cf93534b9bcd0923f314c389d571e91e7f8
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPB9 ACE2 SPAAR	3.21e-04	187	32	3	e6afbaed352310a1cb49571a2aae18be1f533c9a
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPB9 ACE2 SPAAR	3.21e-04	187	32	3	b6ecf55014f246461bf1ca12f24cb4d046661fa4
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPB9 ACE2 SPAAR	3.21e-04	187	32	3	9fb15f24b9b364b0c4704ec98aec236eaec5411c
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLEC7A CD1C HTR1F	3.21e-04	187	32	3	8e1d6d25db5b5c91a651bb2d66edfcf073a31704
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LPAR1 ACKR3 AP3B2	3.21e-04	187	32	3	0d4b7da81036c2aa678654b9fe49c939d08fcd9b
ToppCell	3'_v3-bone_marrow-Myeloid_Dendritic\|bone_marrow / Manually curated celltypes from each tissue	CD1C GPRC5C LDLRAD4	3.36e-04	190	32	3	6892c603037b61ef88d6ca01b7592dc0d347d63b
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_Tregs\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CLEC7A ADAM12 SGPP2	3.36e-04	190	32	3	f69a4733b5d1542ab4d0eb44856f2c5c34c18b9e
ToppCell	tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	FNDC4 CD1C LDLRAD4	3.36e-04	190	32	3	58a6ab70737d719ca9725ac087f20dfe9be0463e
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPB9 MFRP ACKR3	3.41e-04	191	32	3	14144e0b0c12757358c9aa5dfc9b7edb2edde5c7
ToppCell	COPD-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	ADAM12 LDLRAD4 SGPP2	3.41e-04	191	32	3	3ae18bc4e3dff49b5d5958da8ebc3f747274b69c
ToppCell	(3)_MNP-(3)_DC_1\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	SLC13A4 LDLRAD4 PTK2	3.41e-04	191	32	3	cf0ea54670ed478c3302ccfbee9f6b6706e49fcd
ToppCell	facs-Heart-LA-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 GPRC5C TACR3	3.41e-04	191	32	3	9c5d88f0d3c834c2419ec3da74652175153ba9df
ToppCell	facs-Heart-LA-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 GPRC5C TACR3	3.41e-04	191	32	3	a7494191a92984e5f53610bbbedd6714e9169e1c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HTR1F GRM3 ADAM12	3.46e-04	192	32	3	09cb5b89a164ac7444774ccc8c90323c8ea2026b
ToppCell	metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	FNDC4 CD1C GPRC5C	3.46e-04	192	32	3	f18da8db573e584c8b90df0814afcf020360108e
ToppCell	cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CLEC7A CD1C LDLRAD4	3.46e-04	192	32	3	3674c81aeee6f055cfa854d9429c1b7f5789d0fc
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 GPRC5C ACKR3	3.46e-04	192	32	3	e5117cdb8af220f60bd1410262078c0306667b4a
ToppCell	Control-Treg\|Control / Disease group and Cell class	CLEC7A ADAM12 SGPP2	3.46e-04	192	32	3	3a9a8ac2aa278adde848608f9bb92a002dbb9bcc
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HTR1F GRM3 ADAM12	3.52e-04	193	32	3	dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68
ToppCell	Children_(3_yrs)-Immune-monocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CLEC7A CD1C LDLRAD4	3.52e-04	193	32	3	58e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH2 DNAH10 LDLRAD4	3.52e-04	193	32	3	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HTR1F GRM3 ADAM12	3.52e-04	193	32	3	2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH2 EFCAB2 DNAH10	3.52e-04	193	32	3	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	367C-Myeloid-Dendritic\|367C / Donor, Lineage, Cell class and subclass (all cells)	CLEC7A CD1C LDLRAD4	3.52e-04	193	32	3	365e831ae6ac67fb36d8d70ef139f4ae7e32c83f
ToppCell	nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CLEC7A CD1C LDLRAD4	3.57e-04	194	32	3	bde6830a281f7cd7fd1733e40a41ddd2673ba88e
ToppCell	390C-Myeloid-Dendritic-cDC2\|390C / Donor, Lineage, Cell class and subclass (all cells)	CLEC7A CD1C LDLRAD4	3.57e-04	194	32	3	705fa653c11b6c8a427e007533aa4a4bb5845078
ToppCell	cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CLEC7A CD1C LDLRAD4	3.57e-04	194	32	3	74d588de2f84a4ef112fd642f7e112a542d5ef11
ToppCell	368C-Myeloid-Dendritic-cDC2\|368C / Donor, Lineage, Cell class and subclass (all cells)	CLEC7A CD1C LDLRAD4	3.57e-04	194	32	3	eb9656d6d2da9aa074e6f5c06d750a6f9828208a
ToppCell	10x5'-Liver-Myeloid_Dendritic\|Liver / Manually curated celltypes from each tissue	CD1C LDLRAD4 PTK2	3.57e-04	194	32	3	e6391bc7073831847c469ef0b0c437118e1f151f
ToppCell	368C-Myeloid-Dendritic\|368C / Donor, Lineage, Cell class and subclass (all cells)	CLEC7A CD1C LDLRAD4	3.57e-04	194	32	3	4f88759d92ac229b1edd2d4b69b878bbf2d9b6bd
ToppCell	367C-Myeloid-Dendritic-cDC2\|367C / Donor, Lineage, Cell class and subclass (all cells)	CLEC7A CD1C LDLRAD4	3.57e-04	194	32	3	d0ffba657c7308feecaa62dd54c920d32be0f129
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLEC7A CD1C LDLRAD4	3.62e-04	195	32	3	7dd0cb8f3753fe761fac200cbd161708b6528c51
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLEC7A CD1C LDLRAD4	3.62e-04	195	32	3	9cfbdb528088ad0ab100c7431c7d8f140a846de8
ToppCell	Adult-Immune-monocyte-D231\|Adult / Lineage, Cell type, age group and donor	CLEC7A CD1C LDLRAD4	3.62e-04	195	32	3	ea24da6fea1487acb1e56c28c0649858cc0a12bd
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH2 EFCAB2 DNAH10	3.62e-04	195	32	3	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLEC7A CD1C LDLRAD4	3.62e-04	195	32	3	66f3b3e15eaa21bc7cf2f204cac81de1a160a748
ToppCell	(3)_DC_2\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CLEC7A CD1C LDLRAD4	3.62e-04	195	32	3	3d656e13f1440a3624fe890f59343f7313b51740
ToppCell	356C-Myeloid-Dendritic-cDC2\|356C / Donor, Lineage, Cell class and subclass (all cells)	CLEC7A CD1C LDLRAD4	3.62e-04	195	32	3	4c9a2167d8cfe40dfd609c303ada5b5ef800bd8f
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLEC7A CD1C LDLRAD4	3.62e-04	195	32	3	bbf5f79be4fcea754328f1af7ee5625075248100
Computational	GPCR signaling pathways (immune and neuro).	TACR3 GRM3 HCRTR2	2.94e-04	90	16	3	MODULE_375
Computational	Genes in the cancer module 146.	TACR3 LPAR1 HCRTR2	4.25e-04	102	16	3	MODULE_146
Computational	Genes in the cancer module 289.	TACR3 GRM3 HCRTR2	7.52e-04	124	16	3	MODULE_289
Computational	Genes in the cancer module 288.	TACR1 TACR3	1.34e-03	37	16	2	MODULE_288
Computational	Genes in the cancer module 27.	TACR3 GRM3 LPAR1 HCRTR2	1.55e-03	355	16	4	MODULE_27
Drug	chloropyramine	TACR1 TACR3 PTK2	8.23e-07	14	31	3	CID000025294
Drug	senktide	TACR1 TACR3	1.79e-06	2	31	2	ctd:C054724
Drug	aganodine	TACR1 TACR3 LPAR1	3.97e-06	23	31	3	CID000176878
Drug	(N-N'-bis-(2-(1H-indol-3-yl)-ethyl)-N,N'-bis-(3-thiomorpholin-4-yl-propyl)-phthalamide)	TACR1 TACR3	5.38e-06	3	31	2	ctd:C502587
Drug	NSC237521	CLEC7A CD1C TACR1 AP3B1 AP3B2	8.90e-06	210	31	5	CID000428410
Drug	Men10354	TACR1 TACR3	1.07e-05	4	31	2	CID003083370
Drug	4-quinolinecarboxamide	TACR1 TACR3	1.07e-05	4	31	2	CID003753329
Drug	L-365,260	TACR1 TACR3 PTK2	1.72e-05	37	31	3	CID000104929
Drug	AC1L51LV	TACR1 TACR3	1.79e-05	5	31	2	CID000196380
Drug	2-(4-nitrophenyl)benzoxazole	TACR1 TACR3	1.79e-05	5	31	2	CID000070047
Drug	2-methyl-5-HT	TACR1 TACR3 HTR1F	2.18e-05	40	31	3	CID000001574
Drug	Ranatachykinin A	TACR1 TACR3	2.68e-05	6	31	2	CID000195814
Drug	Urechistachykinin I	TACR1 TACR3	2.68e-05	6	31	2	CID000192432
Drug	4-phenylpiperidine-4-carboxamide	TACR1 TACR3	2.68e-05	6	31	2	CID003017129
Drug	Spm-SP	TACR1 TACR3	2.68e-05	6	31	2	CID003081857
Drug	L-659,837	TACR1 TACR3	3.75e-05	7	31	2	CID006444163
Drug	4,6-dichloroindole-2-carboxylic acid	TACR1 GRM3	3.75e-05	7	31	2	CID000127988
Drug	GR159897	TACR1 TACR3	3.75e-05	7	31	2	CID003570748
Drug	SB 235375	TACR1 TACR3	3.75e-05	7	31	2	CID009846078
Drug	S 5192	TACR1 TACR3	3.75e-05	7	31	2	CID003946663
Drug	Men 10456	TACR1 TACR3	3.75e-05	7	31	2	CID000189859
Drug	L015496	TACR1 TACR3	3.75e-05	7	31	2	CID004529080
Drug	AC1O44I5	TACR1 TACR3	3.75e-05	7	31	2	CID006324620
Drug	Neurokinin A-oh	TACR1 TACR3	3.75e-05	7	31	2	CID000147040
Drug	DAU 6285	TACR1 TACR3	3.75e-05	7	31	2	CID000129927
Drug	LY303870	TACR1 TACR3	3.75e-05	7	31	2	CID003086681
Drug	Lom-TK-I	TACR1 TACR3	5.00e-05	8	31	2	CID000195503
Drug	AC1L4Z4R	TACR1 TACR3	5.00e-05	8	31	2	CID000194918
Drug	Bhsar-SP	TACR1 TACR3	5.00e-05	8	31	2	CID000163829
Drug	AC1Q5IQA	TACR1 TACR3	5.00e-05	8	31	2	CID000163732
Drug	Amino-senktide	TACR1 TACR3	5.00e-05	8	31	2	CID000128590
Drug	5-methoxytryptamine	TACR1 TACR3 HTR1F	5.41e-05	54	31	3	CID000001833
Drug	phyllomedusin	TACR1 TACR3	6.42e-05	9	31	2	CID000168489
Drug	inaperisone	TACR1 TACR3	6.42e-05	9	31	2	CID000065860
Drug	AC1MIXOF	TACR1 TACR3	6.42e-05	9	31	2	CID003081850
Drug	SP(3-11)	TACR1 TACR3	6.42e-05	9	31	2	CID003084968
Drug	Sp(7-11)	TACR1 TACR3	6.42e-05	9	31	2	CID003084967
Drug	Uperolein	TACR1 TACR3	8.02e-05	10	31	2	CID003085088
Drug	R 487	TACR1 TACR3	8.02e-05	10	31	2	CID000131469
Drug	R396	TACR1 TACR3	8.02e-05	10	31	2	CID000164286
Drug	AC1L2Y4S	TACR1 TACR3	8.02e-05	10	31	2	CID000130848
Drug	Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; HL60; HT_HG-U133A	CLEC7A GPRC5C AKAP1 LPAR1	8.82e-05	174	31	4	1276_DN
Drug	dhS1P	TACR1 LPAR1 SGPP2	9.43e-05	65	31	3	CID000000520
Drug	Nka-(4-10)	TACR1 TACR3	9.79e-05	11	31	2	CID000122230
Drug	ezlopitant	TACR1 TACR3	9.79e-05	11	31	2	CID000188927
Drug	AC1Q5XN5	TACR1 TACR3	9.79e-05	11	31	2	CID000190946
Drug	Mdl 28,564	TACR1 TACR3	9.79e-05	11	31	2	CID003081745
Drug	Cp96	TACR1 TACR3	9.79e-05	11	31	2	CID000086380
Drug	AC1L1DD6	ACE2 TACR1 MFRP PTK2	9.85e-05	179	31	4	CID000002299
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	GPRC5C AKAP1 ALG6 ACKR3	1.14e-04	186	31	4	1066_DN
Drug	Neurotensin (1-8)	ACE2 PTK2	1.17e-04	12	31	2	CID000196178
Drug	[Sar9]-Substance-?P	TACR1 TACR3	1.17e-04	12	31	2	CID005049868
Drug	Mdl 29913	TACR1 TACR3	1.17e-04	12	31	2	CID003081272
Drug	norbiotin	TACR1 TACR3 GRM3	1.28e-04	72	31	3	CID000446903
Drug	Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	CLEC7A CD1C AKAP1 ADAM12	1.37e-04	195	31	4	4172_UP
Drug	PD140548	TACR1 TACR3	1.39e-04	13	31	2	CID005311347
Drug	Naspm	TACR1 GRM3	1.39e-04	13	31	2	CID000129695
Drug	Scyliorhinin I	TACR1 TACR3	1.39e-04	13	31	2	CID000147048
Drug	Sulfamethizole [144-82-1]; Down 200; 14.8uM; HL60; HT_HG-U133A	GPRC5C LPAR1 LDLRAD4 PTK2	1.42e-04	197	31	4	2536_DN
Drug	Stachydrine hydrochloride; Up 200; 22.2uM; HL60; HG-U133A	EFCAB2 AKAP1 ADAM12 LDLRAD4	1.42e-04	197	31	4	1751_UP
Drug	Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; HL60; HG-U133A	EFCAB2 CLEC7A LPAR1 LDLRAD4	1.48e-04	199	31	4	1596_UP
Drug	AC1L9HP3	AP3B1 ALG6 AP3B2	1.50e-04	76	31	3	CID000445265
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; PC3; HT_HG-U133A	FNDC4 ACE2 ADAM12 AP3B2	1.51e-04	200	31	4	4006_UP
Drug	Gr 73632	TACR1 TACR3	1.62e-04	14	31	2	CID000119599
Drug	sumatriptan	TACR1 TACR3 HTR1F	1.75e-04	80	31	3	CID000005358
Drug	Ino-Hcy	TACR1 MFRP GRM3	1.95e-04	83	31	3	CID000193585
Drug	Gr-94800	TACR1 TACR3	2.13e-04	16	31	2	CID005487475
Drug	Fk 224	TACR1 TACR3	2.13e-04	16	31	2	CID006437864
Drug	TMOF	ACE2 PTK2	2.13e-04	16	31	2	CID005488810
Drug	Men 10627	TACR1 TACR3	2.13e-04	16	31	2	CID006438356
Drug	nifedipine	ACE2 TACR1 TACR3 MFRP GRM3	2.26e-04	415	31	5	CID000004485
Drug	thiorphan	ACE2 TACR1 TACR3	2.32e-04	88	31	3	CID000003132
Drug	substance P methyl ester	TACR1 TACR3	2.41e-04	17	31	2	CID004588685
Drug	L-732,138	TACR1 TACR3	2.41e-04	17	31	2	CID000132837
Drug	L-703, 606 oxalate	TACR1 TACR3	2.41e-04	17	31	2	CID000003851
Drug	alaninamide	TACR1 TACR3	2.41e-04	17	31	2	CID000350287
Drug	MEN 11420	TACR1 TACR3	2.41e-04	17	31	2	CID003086682
Drug	AC1L1CLB	TACR1 TACR3 HTR1F	2.64e-04	92	31	3	CID000001951
Drug	Dimethyl C7	TACR1 TACR3	2.71e-04	18	31	2	CID000123994
Drug	MNQX	TACR1 GRM3	2.71e-04	18	31	2	CID000130818
Drug	GR 64349	TACR1 TACR3	3.02e-04	19	31	2	CID003036081
Drug	biotinyl-L-lysine	TACR1 TACR3 GRM3	3.28e-04	99	31	3	CID000083814
Drug	Sendide	TACR1 TACR3	3.36e-04	20	31	2	CID000122140
Drug	dibenzyl	TACR1 TACR3	3.36e-04	20	31	2	CID000007647
Drug	AC1L1KWW	TACR1 TACR3	3.36e-04	20	31	2	CID000005688
Drug	SB 204070	TACR1 HTR1F	3.36e-04	20	31	2	CID000121880
Drug	neurokinin-1 receptor antagonist	TACR1 TACR3	3.71e-04	21	31	2	CID001122655
Drug	ARC 239	TACR1 TACR3	3.71e-04	21	31	2	CID000609483
Drug	chloride	ACE2 TACR1 TACR3 SLC13A4 HTR1F LPAR1 PTK2	3.82e-04	1029	31	7	CID000000312
Drug	N-acetyl-L-tryptophan	TACR1 TACR3	4.07e-04	22	31	2	CID000002002
Drug	L000576	AP3B1 AP3B2	4.07e-04	22	31	2	CID003420831
Drug	Sp(1-7)	TACR1 TACR3	4.07e-04	22	31	2	CID000115322
Drug	Substance P Octapeptide	TACR1 TACR3	4.46e-04	23	31	2	CID000171298
Drug	Hoe 140	ACE2 TACR1 TACR3	4.47e-04	110	31	3	CID000071362
Drug	estradiol-17 beta-benzoate	TACR1 TACR3	4.86e-04	24	31	2	ctd:C010452
Drug	SR 142801	TACR1 TACR3	4.86e-04	24	31	2	CID000219077
Drug	Epiamastatin hydrochloride	ACE2 TACR1 TACR3	5.09e-04	115	31	3	CID000003237
Drug	Salnacedin	TACR1 TACR3	5.28e-04	25	31	2	CID003058743
Drug	Bhg-(2-1)fuc	TACR1 TACR3	5.28e-04	25	31	2	CID005287784
Drug	L-158,809	ACE2 TACR3	5.28e-04	25	31	2	CID000123856
Disease	Endomyocardial Fibrosis	FNDC5 ACE2	3.83e-05	9	31	2	C0553980
Disease	seborrheic dermatitis	TACR1 GRM3	2.01e-04	20	31	2	EFO_1000764
Disease	pulmonary hypertension (is_implicated_in)	ACE2 PTK2	4.56e-04	30	31	2	DOID:6432 (is_implicated_in)
Disease	Paroxysmal atrial fibrillation	SLC9B1 DNAH10 PTK2	5.84e-04	156	31	3	C0235480
Disease	Persistent atrial fibrillation	SLC9B1 DNAH10 PTK2	5.84e-04	156	31	3	C2585653
Disease	familial atrial fibrillation	SLC9B1 DNAH10 PTK2	5.84e-04	156	31	3	C3468561
Disease	Atrial Fibrillation	SLC9B1 DNAH10 PTK2	6.29e-04	160	31	3	C0004238
Disease	Alcohol Use Disorder	TACR1 TACR3	9.83e-04	44	31	2	C0001956
Disease	forced expiratory volume, response to bronchodilator	EFCAB2 HTR1F LPAR1 ACKR3	1.16e-03	445	31	4	EFO_0004314, GO_0097366
Disease	hepatocellular carcinoma (implicated_via_orthology)	LPAR1 PTK2	1.22e-03	49	31	2	DOID:684 (implicated_via_orthology)
Disease	birth weight, pelvic organ prolapse	TACR1 AP3B1	1.22e-03	49	31	2	EFO_0004344, EFO_0004710
Disease	response to beta blocker, heart rate	EFCAB2 TACR1	1.64e-03	57	31	2	EFO_0004326, EFO_0007766
Disease	Schizophrenia	TACR3 HTR1F GRM3 ADAM12 LPAR1	2.11e-03	883	31	5	C0036341
Disease	wheezing	SLC9B1 AP3B1	2.13e-03	65	31	2	EFO_0009715
Disease	Alcohol abuse	TACR1 TACR3	2.26e-03	67	31	2	C0085762
Disease	Alcoholic Intoxication, Chronic	TACR1 TACR3 GRM3	2.76e-03	268	31	3	C0001973
Disease	S-warfarin measurement	ADAM12 LDLRAD4	4.67e-03	97	31	2	EFO_0803323
Disease	reaction time measurement	AP3B1 DNAH10 ACKR3 LDLRAD4	4.78e-03	658	31	4	EFO_0008393
Disease	cortical thickness, neuroimaging measurement	LPAR1 ACKR3	5.97e-03	110	31	2	EFO_0004346, EFO_0004840

Protein segments in the cluster

Peptide	Gene	Start	Entry
WLMLPDGITVEVIVV	AKAP1	701	Q92667
GIMITIVWIISVFIS	HTR1F	141	P30939
LMTVVVLIGLTVRWT	ALG6	6	Q9Y672
ILVQIVMVSVWLILE	GRM3	696	Q14832
NIRIVLVGVEVWNDM	ADAM12	256	O43184
VEEWGQVVIIHMLTR	AP3B1	236	O00203
VEEWGQVVIISMLTR	AP3B2	231	Q13367
TAFVIIMIIWVLAIT	NPFFR2	261	Q9Y5X5
NIWVGMITQEEVVEV	MFRP	486	Q9BY79
TMTVLWGTQEIIVAE	EFCAB2	136	Q5VUJ9
EELVVQVDGQWLMVT	HSPB9	66	Q9BQS6
NRRVVVVIVVIWTMA	LPAR1	161	Q92633
VVIVVIWTMAIVMGA	LPAR1	166	Q92633
LVIMRQWVCVVLLVV	OR4A47	131	Q6IF82
VEVIINTEWLIITLV	GPRC5C	166	Q9NQ84
NSIVIIWIVSCIIMI	HCRTR2	171	O43614
SMNWIALVVIVPLVI	CD1C	301	P29017
QTGEVVIIVVVLLMW	FNDC4	166	Q9H6D8
VIIVVVLLMWAAVIG	FNDC4	171	Q9H6D8
VIGMIANSVVVWVNI	ACKR3	56	P25106
IWLIVFGVVMGVIVV	ACE2	741	Q9BYF1
TLSLIGEVIEIWMLV	DNAH10	1466	Q8IVF4
ILEVIEMILTVQRQW	DNAH2	1436	Q9P225
IGLVIVMVAINTWGV	SLC13A4	591	Q9UKG4
VAQWAMETAVIGVVV	SPAAR	11	A0A1B0GVQ0
LIGVITENPVWIIME	PTK2	486	Q05397
RTGEVLIIVVVLFMW	FNDC5	151	Q8NAU1
VIVVTSVVGNVVVMW	TACR1	41	P25103
VAVAVLGNLIVIWII	TACR3	96	P29371
LIIIWVLVMYIGQVA	SGPP2	121	Q8IWX5
VILVIAVVLGTMAIW	CLEC7A	56	Q9BXN2
ILVWMVTITGETLEI	SLC24A5	351	Q71RS6
VIITNGVILFVIWCM	SLC9B1	66	Q4ZJI4
AQIIIIVVVVTVMVV	LDLRAD4	66	O15165
IVVVVTVMVVVIVCL	LDLRAD4	71	O15165